KBRA Assigns Preliminary Ratings to ACHM Trust 2025-HE1 (ACHM 2025-HE1)

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 3 classes of mortgage-backed notes from ACHM Trust 2025-HE1 (ACHM 2025-HE1), a $210.9 million RMBS transaction sponsored by Lendage, LLC, d/b/a Achieve Home Loans (AHL or Achieve Home Loans) and Sutton Funding LLC (retained sponsor). The transaction consists entirely of first and second lien home equity line of credit (HELOC) loans. The underlying pool is seasoned one month and comprises of 3,307 loans originated by Achieve Home Loans. The HELOC collateral consists of fixed-rate mortgages (FRMs) with 5-year initial draw windows and fully amortizing 10-year (93.2%), 15-year (1.2%) and 30-year (5.6%) terms. As of the cut-off date, the borrowers in the loan pool have an outstanding aggregate current balance of $210.9 million from the combined credit limit of $213.7 million (a 98.7% current draw percentage, also referred to as the utilization rate).

The ACHM 2025-HE1 deal structure incorporates a pro-rata/sequential-pay hybrid payment waterfall that is subject to the satisfaction of an overcollateralization test and two performance triggers – a Cumulative Loss Trigger and a Delinquency Trigger. If the overcollateralization amount remains above the target and both performance triggers are satisfied, available funds are allocated pro-rata to the Class A, B and C Notes up to the Principal Distribution Amount. However, if either the overcollateralization amount falls to or below the overcollateralization floor or either performance trigger fails, the Class A, B and C Notes will be paid down sequentially. Interest to the Class A, B and C Notes is distributed sequentially but prioritized before paying down any of the Notes. The deal structure also includes a Reserve Account to fund draws and Overcollateralization that are both fully funded and replenished by the waterfall.

To access ratings and relevant documents, click here.

Click here to view the report.

Recent Publications

• RMBS KCAT
• ACHM 2025-HE1 Tear Sheet

Methodologies

• RMBS: U.S. RMBS Rating Methodology
• Structured Finance: Global Structured Finance Counterparty Methodology
• ESG Global Rating Methodology

Disclosures

Further information on key credit considerations, sensitivity analyses that consider what factors can affect these credit ratings and how they could lead to an upgrade or a downgrade, and ESG factors (where they are a key driver behind the change to the credit rating or rating outlook) can be found in the full rating report referenced above.

A description of all substantially material sources that were used to prepare the credit rating and information on the methodology(ies) (inclusive of any material models and sensitivity analyses of the relevant key rating assumptions, as applicable) used in determining the credit rating is available in the Information Disclosure Form(s) located here.

Information on the meaning of each rating category can be located here.

Further disclosures relating to this rating action are available in the Information Disclosure Form(s) referenced above. Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at www.kbra.com.

About KBRA

Kroll Bond Rating Agency, LLC (KBRA), one of the major credit rating agencies (CRA), is a full-service CRA registered with the U.S. Securities and Exchange Commission as an NRSRO. Kroll Bond Rating Agency Europe Limited is registered as a CRA with the European Securities and Markets Authority. Kroll Bond Rating Agency UK Limited is registered as a CRA with the UK Financial Conduct Authority. In addition, KBRA is designated as a Designated Rating Organization (DRO) by the Ontario Securities Commission for issuers of asset-backed securities to file a short form prospectus or shelf prospectus. KBRA is also recognized as a Qualified Rating Agency by Taiwan’s Financial Supervisory Commission and is recognized by the National Association of Insurance Commissioners as a Credit Rating Provider (CRP) in the U.S.

Doc ID: 1008524